Michelle L Henninger1, Carmit K Mcmullen2, Alison J Firemark3, Allison L Naleway4, Nora B Henrikson5, Joseph A Turcotte6. 1. Research Program Manager at the Center for Health Research in Portland, OR. michelle.l.henninger@kpchr.org. 2. Senior Investigator at the Center for Health Research in Portland, OR. carmit.mcmullen@kpchr.org. 3. Research Associate at the Center for Health Research in Portland, OR. alison.j.firemark@kpchr.org. 4. Senior Investigator at the Center for Health Research in Portland, OR. allison.naleway@kpchr.org. 5. Research Associate at the Group Health Research Institute in Seattle, WA. henrikson.n@ghc.org. 6. Principal at the CGA Group in Seattle, WA. joe@cgagroup.net.
Abstract
INTRODUCTION: Human papillomavirus (HPV) is the most common sexually transmitted infection in the US and is associated with multiple types of cancer. Although effective HPV vaccines have been available since 2006, coverage rates in the US remain much lower than with other adolescent vaccinations. Prior research has shown that a strong recommendation from a clinician is a critical determinant in HPV vaccine uptake and coverage. However, few published studies to date have specifically addressed the issue of helping clinicians communicate more effectively with their patients about the HPV vaccine. OBJECTIVE: To develop one or more novel interventions for helping clinicians make strong and effective recommendations for HPV vaccination. METHODS: Using principles of user-centered design, we conducted qualitative interviews, interviews with persons from analogous industries, and a data synthesis workshop with multiple stakeholders. RESULTS: Five potential intervention strategies targeted at health care clinicians, youth, and their parents were developed. The two most popular choices to pursue were a values-based communication strategy and a puberty education workbook. CONCLUSION: User-centered design is a useful strategy for developing potential interventions to improve the rate and success of clinicians recommending the HPV vaccine. Further research is needed to test the effectiveness and acceptability of these interventions in clinical settings.
INTRODUCTION:Human papillomavirus (HPV) is the most common sexually transmitted infection in the US and is associated with multiple types of cancer. Although effective HPV vaccines have been available since 2006, coverage rates in the US remain much lower than with other adolescent vaccinations. Prior research has shown that a strong recommendation from a clinician is a critical determinant in HPV vaccine uptake and coverage. However, few published studies to date have specifically addressed the issue of helping clinicians communicate more effectively with their patients about the HPV vaccine. OBJECTIVE: To develop one or more novel interventions for helping clinicians make strong and effective recommendations for HPV vaccination. METHODS: Using principles of user-centered design, we conducted qualitative interviews, interviews with persons from analogous industries, and a data synthesis workshop with multiple stakeholders. RESULTS: Five potential intervention strategies targeted at health care clinicians, youth, and their parents were developed. The two most popular choices to pursue were a values-based communication strategy and a puberty education workbook. CONCLUSION: User-centered design is a useful strategy for developing potential interventions to improve the rate and success of clinicians recommending the HPV vaccine. Further research is needed to test the effectiveness and acceptability of these interventions in clinical settings.
Authors: Matthew F Daley; Lori A Crane; Lauri E Markowitz; Sandra R Black; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Sami L Gottlieb; Nicole Liddon; Shannon Stokley; L Miriam Dickinson; Allison Kempe Journal: Pediatrics Date: 2010-08-02 Impact factor: 7.124
Authors: Paul L Reiter; Brenda Stubbs; Catherine A Panozzo; Dianne Whitesell; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-09-23 Impact factor: 4.254
Authors: Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher Journal: Vaccine Date: 2012-04-03 Impact factor: 3.641
Authors: Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer Journal: Vaccine Date: 2016-01-24 Impact factor: 3.641
Authors: Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-27 Impact factor: 17.586
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: Jill L McCormick; Taylar A Clark; Christopher M Shea; Dean R Hess; Peter K Lindenauer; Nicholas S Hill; Crystal E Allen; MaryJo S Farmer; Ashley M Hughes; Jay S Steingrub; Mihaela S Stefan Journal: Chronic Obstr Pulm Dis Date: 2022-01-27
Authors: Monica Schoch-Spana; Emily K Brunson; Rex Long; Alexandra Ruth; Sanjana J Ravi; Marc Trotochaud; Luciana Borio; Janesse Brewer; Joseph Buccina; Nancy Connell; Laura Lee Hall; Nancy Kass; Anna Kirkland; Lisa Koonin; Heidi Larson; Brooke Fisher Lu; Saad B Omer; Walter A Orenstein; Gregory A Poland; Lois Privor-Dumm; Sandra Crouse Quinn; Daniel Salmon; Alexandre White Journal: Vaccine Date: 2020-10-29 Impact factor: 3.641
Authors: Joanna E Bulkley; Carmit K McMullen; Andreea M Rawlings; Robert S Krouse; Melanie C Francisco; Andrew T Sterrett; Andrea N Burnett-Hartman; Pamala A Pawloski; Douglas A Corley; Janice C Colwell; Heather Spencer Feigelson Journal: Qual Life Res Date: 2021-07-12 Impact factor: 4.147